The HMG-CoA reductase inhibitor rosuvastatin and the angiotensin receptor antagonist candesartan attenuate atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes via effects on advanced glycation, oxidative stress and inflammation

Author: Calkin A.   Giunti S.   Sheehy K.   Chew C.   Boolell V.   Rajaram Y.   Cooper M.   Jandeleit-Dahm K.  

Publisher: Springer Publishing Company

ISSN: 0012-186X

Source: Diabetologia, Vol.51, Iss.9, 2008-09, pp. : 1731-1740

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content